BZ: Sorrento Therapeutics shares are trading higher after the company announced it received FDA clearance to proceed with its Phase 1 Clinical trial of its STI-1499 Neutralizing antibody in coronavirus positive patient.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.